Compare GHM & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GHM | HROW |
|---|---|---|
| Founded | 1936 | 1998 |
| Country | United States | United States |
| Employees | N/A | 373 |
| Industry | Industrial Machinery/Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1994 | N/A |
| Metric | GHM | HROW |
|---|---|---|
| Price | $106.46 | $41.37 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | ★ $73.33 | $69.86 |
| AVG Volume (30 Days) | 239.1K | ★ 743.9K |
| Earning Date | 06-08-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 0.90 | N/A |
| EPS | ★ 1.12 | N/A |
| Revenue | ★ $245,293,000.00 | N/A |
| Revenue This Year | $14.54 | $31.62 |
| Revenue Next Year | $18.23 | $50.77 |
| P/E Ratio | $92.86 | ★ N/A |
| Revenue Growth | ★ 16.86 | N/A |
| 52 Week Low | $46.08 | $28.54 |
| 52 Week High | $125.82 | $54.98 |
| Indicator | GHM | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 48.16 | 51.28 |
| Support Level | $88.46 | $40.56 |
| Resistance Level | $110.01 | $41.94 |
| Average True Range (ATR) | 5.33 | 1.99 |
| MACD | -1.91 | -0.37 |
| Stochastic Oscillator | 19.81 | 12.09 |
Graham Corp designs and manufactures mission-critical fluid, power, heat transfer, vacuum, and mixing technologies for the Defense, Energy & Process, and Space industries. In Defense, its equipment is used in nuclear and non-nuclear propulsion, power, fluid transfer, thermal management, and mixing systems. In Energy & Process industries, it supplies equipment for vacuum, heat transfer, mixing, and fluid transfer applications used in oil refining, chemical facilities, fertilizers, ethylene, methanol, energetics, food & beverage, medical, and alternative energy applications such as hydrogen and geothermal processes. In the Space industry, its equipment is used in propulsion, power, thermal management, mixing, and life support systems. It operates in the United States and other countries.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company partners with U.S. eyecare professionals to develop products used to manage ophthalmic conditions affecting both the front and back of the eye, such as dry eye disease, cataracts, refractive errors, glaucoma, etc. Its portfolio of branded ophthalmic pharmaceuticals includes Iheezo, Vevye, Byooviz Opuviz, Natacyn, Maxitrol, Maxidex, etc. Additionally, the company's development pipeline comprises candidates like MELT-300, H-N08, CR-01, and MELT-210, being developed to address unmet needs in eye care and selected adjacent markets. Its reportable segments are: Branded, which derives maximum revenue, and ImprimisRx.